Xiangyan Wu
Impact in
-
- Cancer-related molecular mechanisms research
-
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA modifications and cancer 5
- Metabolomics and Mass Spectrometry Studies 2
- RNA Research and Splicing 2
- Oncology 7
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Jun Peng (7 shared papers)Meizhu Wu (10 shared papers)Zhiqing Shen (9 shared papers)Youqin Chen (8 shared papers)Nathaniel Weygant (4 shared papers)Liya Liu (7 shared papers)Dongfeng Qu (1 shared paper)Aling Shen (8 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Cancers (2 papers)Frontiers in Pharmacology (1 paper)PLoS ONE (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiangyan Wu
19 papers receiving 352 citations
Peers
Comparison fields: 5 of 63
- Cancer Research 62
- Oncology 66
- Molecular Biology 168
- Cardiology and Cardiovascular Medicine 49
- Immunology 39
Countries citing papers authored by Xiangyan Wu
This map shows the geographic impact of Xiangyan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyan Wu more than expected).
Fields of papers citing papers by Xiangyan Wu
This network shows the impact of papers produced by Xiangyan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyan Wu. The network helps show where Xiangyan Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangyan Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 57 | |
| 2 | 2020 | 57 | |
| 3 | 2020 | 57 | |
| 4 | 2020 | 24 | |
| 5 | 2020 | 21 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 18 | |
| 8 | 2022 | 17 | |
| 9 | 2020 | 15 | |
| 10 | 2021 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2019 | 13 | |
| 13 | 2021 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 2022 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2023 | 2 | |
| 18 | 2023 | 1 | |
| 19 | [Epithelioid sarcoma of tongue:report of a case]. | 2015 | 1 |
About Xiangyan Wu
Xiangyan Wu is a scholar working on Molecular Biology, Oncology, Immunology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 19 papers that have together received 354 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Renin-Angiotensin System Studies (3 papers), Ferroptosis and cancer prognosis (2 papers), Galectins and Cancer Biology (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune cells in cancer (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (62 citations), Oncology (66 citations), Molecular Biology (168 citations), Cardiology and Cardiovascular Medicine (49 citations) and Immunology (39 citations). Xiangyan Wu has collaborated with scholars based in China and United States. Frequent co-authors include Jun Peng, Meizhu Wu, Zhiqing Shen, Youqin Chen, Nathaniel Weygant, Liya Liu, Dongfeng Qu, Aling Shen, Courtney W. Houchen and Ying Cheng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Cancers, Frontiers in Pharmacology, PLoS ONE and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.